Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 13
2005 11
2006 11
2007 4
2008 10
2009 13
2010 21
2011 25
2012 18
2013 23
2014 35
2015 19
2016 18
2017 19
2018 10
2019 9
2020 4
2021 5
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

243 results
Results by year
Filters applied: . Clear all
Page 1
Targeting glycans for CAR therapy: The advent of sweet CARs.
Raglow Z, McKenna MK, Bonifant CL, Wang W, Pasca di Magliano M, Stadlmann J, Penninger JM, Cummings RD, Brenner MK, Markovitz DM. Raglow Z, et al. Mol Ther. 2022 Sep 7;30(9):2881-2890. doi: 10.1016/j.ymthe.2022.07.006. Epub 2022 Jul 12. Mol Ther. 2022. PMID: 35821636 Review.
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Steffin DHM, Muhsen IN, Hill LC, Ramos CA, Ahmed N, Hegde M, Wang T, Wu M, Gottschalk S, Whittle SB, Lulla PD, Mamonkin M, Omer B, Rouce RH, Heczey A, Metelitsa LS, Grilley BJ, Robertson C, Torrano V, Lapteva N, Gee AP, Rooney CM, Brenner MK, Heslop HE. Steffin DHM, et al. Blood. 2022 Jul 7;140(1):16-24. doi: 10.1182/blood.2022015728. Blood. 2022. PMID: 35325065 Free article.
Taking T-Cell Oncotherapy Off-the-Shelf.
Mo F, Mamonkin M, Brenner MK, Heslop HE. Mo F, et al. Trends Immunol. 2021 Mar;42(3):261-272. doi: 10.1016/j.it.2021.01.004. Epub 2021 Feb 1. Trends Immunol. 2021. PMID: 33536140 Free PMC article. Review.
243 results